Journal: British Journal of Cancer
Article Title: Lack of correlation of stem cell markers in breast cancer stem cells
doi: 10.1038/bjc.2014.105
Figure Lengend Snippet: The effects of repeated therapy on CSC markers. MCF7 or MDAMB468 cells were treated three times with Doxorubicin (Doxo), Docetaxel (Doce) or with ionizing radiation (Rx). In the top panel; the percentages of MCF7 cells showing a CD24 hi or CD24 low phenotype are shown with or without treatment (the expression levels are defined by gating on the 5% of untreated cells with the highest or lowest expression). In addition, the percentages of cells stained with CD44 or ER are shown underneath. For MDAMB468 cells, data are shown for the percentages of cells with a CD24 low /CD44 hi phenotype (third panel) or that have ALDH activity (bottom panel). Data are mean values with 95% confidence intervals, n =3 for each. * P <0.05; ** P <0.01.
Article Snippet: The luminal-type human breast cancer cell lines MCF7, T47D and ZR75-1 (steroid receptor positive); SKBR3 (HER2+); and triple negative cell lines MDAMB231 (mesenchymal) and MDAMB468 (epithelial, EGFR+) were obtained from ATCC, ECACC or DSMZ and grown in DMEM, RPMI (for T47D) or McCoys 5A (for SKBR3) with 10% fetal bovine serum (all from Invitrogen, Life Technologies Ltd., Paisley, UK) at 37 °C with 5% CO 2 .
Techniques: Expressing, Staining, Activity Assay